These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 14641844)
21. Elimination of lymphatic filariasis: do we have the drugs to complete the job? Bockarie MJ; Deb RM Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694 [TBL] [Abstract][Full Text] [Related]
22. Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study. Irvine MA; Stolk WA; Smith ME; Subramanian S; Singh BK; Weil GJ; Michael E; Hollingsworth TD Lancet Infect Dis; 2017 Apr; 17(4):451-458. PubMed ID: 28012943 [TBL] [Abstract][Full Text] [Related]
23. Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo. Pion SDS; Chesnais CB; Weil GJ; Fischer PU; Missamou F; Boussinesq M Lancet Infect Dis; 2017 Jul; 17(7):763-769. PubMed ID: 28372977 [TBL] [Abstract][Full Text] [Related]
24. A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali. Coulibaly YI; Dicko I; Keita M; Keita MM; Doumbia M; Daou A; Haidara FC; Sankare MH; Horton J; Whately-Smith C; Sow SO PLoS Negl Trop Dis; 2013; 7(5):e2221. PubMed ID: 23675549 [TBL] [Abstract][Full Text] [Related]
25. Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study. Mohammed KA; Haji HJ; Gabrielli AF; Mubila L; Biswas G; Chitsulo L; Bradley MH; Engels D; Savioli L; Molyneux DH PLoS Negl Trop Dis; 2008 Jan; 2(1):e171. PubMed ID: 18235853 [TBL] [Abstract][Full Text] [Related]
26. Maternal Infection Is a Risk Factor for Early Childhood Infection in Filariasis. Bal M; Sahu PK; Mandal N; Satapathy AK; Ranjit M; Kar SK PLoS Negl Trop Dis; 2015; 9(7):e0003955. PubMed ID: 26225417 [TBL] [Abstract][Full Text] [Related]
27. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Gyapong JO; Kumaraswami V; Biswas G; Ottesen EA Expert Opin Pharmacother; 2005 Feb; 6(2):179-200. PubMed ID: 15757416 [TBL] [Abstract][Full Text] [Related]
28. Mass drug treatment for lymphatic filariasis and onchocerciasis. Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963 [No Abstract] [Full Text] [Related]
29. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS; Dokubo EK; Sint TT Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370 [TBL] [Abstract][Full Text] [Related]
30. The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda. Luroni LT; Gabriel M; Tukahebwa E; Onapa AW; Tinkitina B; Tukesiga E; Nyaraga M; Auma AM; Habomugisha P; Byamukama E; Oguttu D; Katabarwa M; Unnasch TR PLoS One; 2017; 12(12):e0189306. PubMed ID: 29253862 [TBL] [Abstract][Full Text] [Related]
31. Determinants of parasite drug resistance in human lymphatic filariasis. Cobo F Rev Esp Quimioter; 2016 Dec; 29(6):288-295. PubMed ID: 27858056 [TBL] [Abstract][Full Text] [Related]
32. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis. Gustavsen KM; Bradley MH; Wright AL Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393 [TBL] [Abstract][Full Text] [Related]
34. Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution. Pacqué M; Muñoz B; Poetschke G; Foose J; Greene BM; Taylor HR Lancet; 1990 Dec; 336(8729):1486-9. PubMed ID: 1979100 [TBL] [Abstract][Full Text] [Related]
35. Filariasis in Africa--treatment challenges and prospects. Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251 [TBL] [Abstract][Full Text] [Related]
36. Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana. Gyapong M; Gyapong JO; Owusu-Banahene G Ann Trop Med Parasitol; 2001 Jan; 95(1):77-86. PubMed ID: 11235557 [TBL] [Abstract][Full Text] [Related]
37. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes. Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870 [TBL] [Abstract][Full Text] [Related]
39. Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India. Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Kirodian BG; Ingole NS; Mehendale AM; Fleckenstein L; Karbwang J; Lazdins-Helds JK Trans R Soc Trop Med Hyg; 2004 Apr; 98(4):205-17. PubMed ID: 15049459 [TBL] [Abstract][Full Text] [Related]
40. The effect of maternal exposure to psychosocial job strain on pregnancy outcomes and child development. Larsen AD Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]